PlantArc Bio Ltd. (TLV:PLNT)
Israel · Delayed Price · Currency is ILS · Price in ILA 202.00
-1.70 (-0.83%)
Aug 13, 2025, 5:24 PM IDT
PlantArc Bio Revenue
In the year 2024, PlantArc Bio had annual revenue of 4.40M ILS, down -7.95%. PlantArc Bio had revenue of 2.26M in the half year ending December 31, 2024, with 6,169.44% growth.
Revenue
4.40M
Revenue Growth
-7.95%
P/S Ratio
1.54
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.40M | -380.00K | -7.95% |
| Dec 31, 2023 | 4.78M | 4.68M | 4,678.00% |
| Dec 31, 2022 | 100.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 56.02B |
| Danel (Adir Yeoshua) | 2.81B |
| Kamada | 622.70M |
| Bait Bakfar | 104.50M |
| SofWave Medical | 234.12M |
| BrainsWay | 161.81M |
| Novolog (Pharm-Up 1966) | 2.07B |
| Ilex Medical | 922.08M |